Evidence map›Paper›PMID 40135928›Full record

ArticleJournal of bacteriology2025

Identification of a novel phage depolymerase against ST11 K64 carbapenem-resistant

Peini Yang, Bin Shan, Xing Hu, Li Xue, Guibo Song, Pingan He, Xu Yang

Abstract read
In one paragraph

Article in Journal of bacteriology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Escherichia coli bacteriophage vB_EcoS_MS2 effectively prevents biofilm formation but shows limited activity against mature biofilms.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Peini YangDepartment of Clinical Laboratory, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Bin ShanDepartment of Clinical Laboratory, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Xing HuDepartment of Clinical Laboratory, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Li XueDepartment of Clinical Laboratory, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Guibo SongDepartment of Clinical Laboratory, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Pingan HeDepartment of Clinical Laboratory, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Xu YangDepartment of Clinical Laboratory, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.ORCID 0009-0000-9798-0903

Funding

Kunming Medical University 2021yk002Kunming Medical University 2024S093Yunnan Provincial Science and Technology Department () 2023Y0641
6 · The paper itself

Abstract

Carbapenem-resistant IMPORTANCE: A novel phage vB_KpnP_IME1309 targeting ST11 K64 carbapenem-resistant

Indexed as

BacteriophagesCarbapenem-Resistant EnterobacteriaceaeGlycoside HydrolasesKlebsiella InfectionsKlebsiella pneumoniaeViral ProteinsAnimalsAnti-Bacterial AgentsCarbapenemsLarvaMothsAnti-Bacterial AgentsCarbapenemsGlycoside HydrolasesViral Proteinsbiofilmcapsular polysaccharideCRKPdepolymerasephage

Identifiers

PMID40135928
PMCPMC12004950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.